• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏 PDE2 过表达的抗心律失常作用的细胞机制。

Cellular Mechanisms of the Anti-Arrhythmic Effect of Cardiac PDE2 Overexpression.

机构信息

Department of Pharmacology and Toxicology, Dresden University of Technology, 01307 Dresden, Germany.

Klinik für Innere Medizin und Kardiologie, Dresden Heart Center, Dresden University of Technology, 01307 Dresden, Germany.

出版信息

Int J Mol Sci. 2021 May 1;22(9):4816. doi: 10.3390/ijms22094816.

DOI:10.3390/ijms22094816
PMID:34062838
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8125727/
Abstract

BACKGROUND

Phosphodiesterases (PDE) critically regulate myocardial cAMP and cGMP levels. PDE2 is stimulated by cGMP to hydrolyze cAMP, mediating a negative crosstalk between both pathways. PDE2 upregulation in heart failure contributes to desensitization to β-adrenergic overstimulation. After isoprenaline (ISO) injections, PDE2 overexpressing mice (PDE2 OE) were protected against ventricular arrhythmia. Here, we investigate the mechanisms underlying the effects of PDE2 OE on susceptibility to arrhythmias.

METHODS

Cellular arrhythmia, ion currents, and Ca-sparks were assessed in ventricular cardiomyocytes from PDE2 OE and WT littermates.

RESULTS

Under basal conditions, action potential (AP) morphology were similar in PDE2 OE and WT. ISO stimulation significantly increased the incidence of afterdepolarizations and spontaneous APs in WT, which was markedly reduced in PDE2 OE. The ISO-induced increase in I seen in WT was prevented in PDE2 OE. Moreover, the ISO-induced, Epac- and CaMKII-dependent increase in I and Ca-spark frequency was blunted in PDE2 OE, while the effect of direct Epac activation was similar in both groups. Finally, PDE2 inhibition facilitated arrhythmic events in perfused WT hearts after reperfusion injury.

CONCLUSION

Higher PDE2 abundance protects against ISO-induced cardiac arrhythmia by preventing the Epac- and CaMKII-mediated increases of cellular triggers. Thus, activating myocardial PDE2 may represent a novel intracellular anti-arrhythmic therapeutic strategy in HF.

摘要

背景

磷酸二酯酶(PDE)对心肌 cAMP 和 cGMP 水平的调节至关重要。PDE2 被 cGMP 刺激以水解 cAMP,介导两条途径之间的负性串扰。心力衰竭中 PDE2 的上调导致对β-肾上腺素能过度刺激的脱敏。在异丙肾上腺素(ISO)注射后,PDE2 过表达小鼠(PDE2 OE)对心室性心律失常有保护作用。在这里,我们研究了 PDE2 OE 对心律失常易感性影响的机制。

方法

在 PDE2 OE 和 WT 同窝仔鼠的心室肌细胞中评估细胞性心律失常、离子电流和 Ca 火花。

结果

在基础条件下,PDE2 OE 和 WT 的动作电位(AP)形态相似。ISO 刺激显著增加了 WT 中的后去极化和自发性 AP 的发生率,而在 PDE2 OE 中则明显减少。在 WT 中观察到的 ISO 诱导的 I 增加在 PDE2 OE 中被阻止。此外,ISO 诱导的、Epac 和 CaMKII 依赖性的 I 和 Ca 火花频率的增加在 PDE2 OE 中减弱,而直接 Epac 激活的作用在两组中相似。最后,PDE2 抑制促进了再灌注损伤后灌注 WT 心脏中的心律失常事件。

结论

较高的 PDE2 丰度通过防止 Epac 和 CaMKII 介导的细胞触发增加来保护 ISO 诱导的心脏性心律失常。因此,激活心肌 PDE2 可能是 HF 中一种新的细胞内抗心律失常治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/8125727/82bad7048999/ijms-22-04816-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/8125727/f9881ac63dd8/ijms-22-04816-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/8125727/64e16723504b/ijms-22-04816-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/8125727/3699df3e2949/ijms-22-04816-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/8125727/3ee4660cae43/ijms-22-04816-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/8125727/43953623aaf7/ijms-22-04816-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/8125727/82bad7048999/ijms-22-04816-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/8125727/f9881ac63dd8/ijms-22-04816-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/8125727/64e16723504b/ijms-22-04816-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/8125727/3699df3e2949/ijms-22-04816-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/8125727/3ee4660cae43/ijms-22-04816-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/8125727/43953623aaf7/ijms-22-04816-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a45/8125727/82bad7048999/ijms-22-04816-g006.jpg

相似文献

1
Cellular Mechanisms of the Anti-Arrhythmic Effect of Cardiac PDE2 Overexpression.心脏 PDE2 过表达的抗心律失常作用的细胞机制。
Int J Mol Sci. 2021 May 1;22(9):4816. doi: 10.3390/ijms22094816.
2
Phosphodiesterase-2 is up-regulated in human failing hearts and blunts β-adrenergic responses in cardiomyocytes.磷酸二酯酶-2 在人衰竭心脏中上调,并使心肌细胞中β-肾上腺素能反应迟钝。
J Am Coll Cardiol. 2013 Oct 22;62(17):1596-606. doi: 10.1016/j.jacc.2013.05.057. Epub 2013 Jun 26.
3
CNP Promotes Antiarrhythmic Effects via Phosphodiesterase 2.CNP 通过磷酸二酯酶 2 促进抗心律失常作用。
Circ Res. 2023 Feb 17;132(4):400-414. doi: 10.1161/CIRCRESAHA.122.322031. Epub 2023 Jan 30.
4
CD44 regulates Epac1-mediated β-adrenergic-receptor-induced Ca-handling abnormalities: implication in cardiac arrhythmias.CD44 调节 Epac1 介导的 β-肾上腺素能受体诱导的钙处理异常:在心律失常中的意义。
J Biomed Sci. 2023 Jul 14;30(1):55. doi: 10.1186/s12929-023-00944-0.
5
β-adrenergic regulation of late Na current during cardiac action potential is mediated by both PKA and CaMKII.β-肾上腺素能调节心脏动作电位中的晚期 Na 电流是由 PKA 和 CaMKII 共同介导的。
J Mol Cell Cardiol. 2018 Oct;123:168-179. doi: 10.1016/j.yjmcc.2018.09.006. Epub 2018 Sep 18.
6
Contribution of the neuronal sodium channel Na1.8 to sodium- and calcium-dependent cellular proarrhythmia.神经元钠通道Na1.8对钠和钙依赖性细胞性心律失常的作用。
J Mol Cell Cardiol. 2020 Jul;144:35-46. doi: 10.1016/j.yjmcc.2020.05.002. Epub 2020 May 11.
7
PDE2-mediated cAMP hydrolysis accelerates cardiac fibroblast to myofibroblast conversion and is antagonized by exogenous activation of cGMP signaling pathways.PDE2 介导的 cAMP 水解加速了心肌成纤维细胞向肌成纤维细胞的转化,而外源性激活 cGMP 信号通路则可以拮抗这种转化。
Am J Physiol Heart Circ Physiol. 2014 Apr 15;306(8):H1246-52. doi: 10.1152/ajpheart.00852.2013. Epub 2014 Feb 14.
8
Calmodulin kinase II inhibition limits the pro-arrhythmic Ca2+ waves induced by cAMP-phosphodiesterase inhibitors.钙调蛋白激酶 II 抑制可限制 cAMP-磷酸二酯酶抑制剂诱导的致心律失常性 Ca2+波。
Cardiovasc Res. 2016 May 1;110(1):151-61. doi: 10.1093/cvr/cvw027. Epub 2016 Feb 4.
9
Maximal acceleration of Ca2+ release refractoriness by β-adrenergic stimulation requires dual activation of kinases PKA and CaMKII in mouse ventricular myocytes.β-肾上腺素能刺激使心肌细胞中Ca2+释放不应期达到最大加速,需要蛋白激酶A(PKA)和钙/钙调蛋白依赖性蛋白激酶II(CaMKII)的双重激活。
J Physiol. 2015 Mar 15;593(6):1495-507. doi: 10.1113/jphysiol.2014.278051. Epub 2014 Oct 7.
10
Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes.抑制 5 型磷酸二酯酶可拮抗搏动心肌细胞中的β2-肾上腺素能信号传导。
Cardiovasc Res. 2015 Jun 1;106(3):408-20. doi: 10.1093/cvr/cvv123. Epub 2015 Apr 7.

引用本文的文献

1
Cardiac Gene Therapy With Phosphodiesterase 2A Limits Remodeling and Arrhythmias in Mouse Models of Heart Failure.用磷酸二酯酶2A进行心脏基因治疗可限制心力衰竭小鼠模型中的重塑和心律失常。
J Am Heart Assoc. 2025 Feb 4;14(3):e037343. doi: 10.1161/JAHA.124.037343. Epub 2025 Feb 3.
2
Cardiac cGMP Regulation and Therapeutic Applications.心脏cGMP调节与治疗应用
Hypertension. 2025 Feb;82(2):185-196. doi: 10.1161/HYPERTENSIONAHA.124.21709. Epub 2024 Dec 11.
3
Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions.

本文引用的文献

1
Therapeutic Implications for PDE2 and cGMP/cAMP Mediated Crosstalk in Cardiovascular Diseases.在心血管疾病中 PDE2 和 cGMP/cAMP 介导的串扰的治疗意义。
Int J Mol Sci. 2020 Oct 10;21(20):7462. doi: 10.3390/ijms21207462.
2
Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week.靶向环鸟苷酸治疗心力衰竭:JACC 每周综述专题。
J Am Coll Cardiol. 2020 Oct 13;76(15):1795-1807. doi: 10.1016/j.jacc.2020.08.031.
3
cGMP Signaling and Modulation in Heart Failure.cGMP 信号转导与心力衰竭的调节。
心脏病理生理学中的纳米域环磷酸腺苷信号传导:开发靶向治疗干预措施的潜力
Physiol Rev. 2025 Apr 1;105(2):541-591. doi: 10.1152/physrev.00013.2024. Epub 2024 Aug 8.
4
The role and mechanism of heme oxygenase-1 in arrhythmias.血红素加氧酶-1 在心律失常中的作用和机制。
J Mol Med (Berl). 2024 Aug;102(8):1001-1007. doi: 10.1007/s00109-024-02462-4. Epub 2024 Jun 28.
5
Abnormal phosphorylation / dephosphorylation and Ca dysfunction in heart failure.心力衰竭中心脏异常的磷酸化/去磷酸化和钙功能障碍。
Heart Fail Rev. 2024 Jul;29(4):751-768. doi: 10.1007/s10741-024-10395-w. Epub 2024 Mar 18.
6
Intertwined regulators: hypoxia pathway proteins, microRNAs, and phosphodiesterases in the control of steroidogenesis.相互交织的调节因子:缺氧途径蛋白、微小RNA和磷酸二酯酶在类固醇生成调控中的作用
Pflugers Arch. 2024 Sep;476(9):1383-1398. doi: 10.1007/s00424-024-02921-4. Epub 2024 Feb 15.
7
Phosphodiesterase in heart and vessels: from physiology to diseases.心脏和血管中的磷酸二酯酶:从生理学到疾病。
Physiol Rev. 2024 Apr 1;104(2):765-834. doi: 10.1152/physrev.00015.2023. Epub 2023 Nov 16.
8
CNP Promotes Antiarrhythmic Effects via Phosphodiesterase 2.CNP 通过磷酸二酯酶 2 促进抗心律失常作用。
Circ Res. 2023 Feb 17;132(4):400-414. doi: 10.1161/CIRCRESAHA.122.322031. Epub 2023 Jan 30.
9
Epac: A Promising Therapeutic Target for Vascular Diseases: A Review.Epac:一种有前景的血管疾病治疗靶点:综述
Front Pharmacol. 2022 Jul 14;13:929152. doi: 10.3389/fphar.2022.929152. eCollection 2022.
10
Editorial of the Special Issue: cGMP-Signaling in Cells and Tissues: Molecular, Functional and Pharmacological Aspects.特刊编辑:细胞和组织中环磷酸鸟苷信号:分子、功能和药理学方面。
Int J Mol Sci. 2022 Jun 10;23(12):6482. doi: 10.3390/ijms23126482.
J Cardiovasc Pharmacol. 2020 May;75(5):385-398. doi: 10.1097/FJC.0000000000000749.
4
PDE2 regulates membrane potential, respiration and permeability transition of rodent subsarcolemmal cardiac mitochondria.PDE2 调节啮齿动物亚肌小节心脏线粒体的膜电位、呼吸和通透性转换。
Mitochondrion. 2019 Jul;47:64-75. doi: 10.1016/j.mito.2019.05.002. Epub 2019 May 15.
5
Antiarrhythmic mechanisms of beta blocker therapy.β受体阻滞剂治疗心律失常的机制。
Pharmacol Res. 2019 Aug;146:104274. doi: 10.1016/j.phrs.2019.104274. Epub 2019 May 14.
6
Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review.心律失常性心肌病:美国心脏病学会最新综述
J Am Coll Cardiol. 2019 May 14;73(18):2328-2344. doi: 10.1016/j.jacc.2019.02.045.
7
Protein Kinase A as a Promising Target for Heart Failure Drug Development.蛋白激酶 A 作为心力衰竭药物研发的有前途的靶点。
Arch Med Res. 2018 Nov;49(8):530-537. doi: 10.1016/j.arcmed.2018.12.008. Epub 2019 Jan 11.
8
Arrhythmogenic Mechanisms in Heart Failure: Linking β-Adrenergic Stimulation, Stretch, and Calcium.心力衰竭中的致心律失常机制:连接β-肾上腺素能刺激、牵张与钙
Front Physiol. 2018 Oct 16;9:1453. doi: 10.3389/fphys.2018.01453. eCollection 2018.
9
Phosphorylation of cardiac voltage-gated sodium channel: Potential players with multiple dimensions.心脏电压门控钠离子通道的磷酸化:具有多维潜在作用的参与者。
Acta Physiol (Oxf). 2019 Mar;225(3):e13210. doi: 10.1111/apha.13210. Epub 2018 Dec 16.
10
Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure.磷酸二酯酶 2 抑制作用优先促进一氧化氮/鸟苷酸环化酶/cGMP 信号转导,逆转心力衰竭的发展。
Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):E7428-E7437. doi: 10.1073/pnas.1800996115. Epub 2018 Jul 16.